FDA Budget Proposal Shifts More Toward User Fees Reliance
This article was originally published in The Tan Sheet
Executive Summary
User fees make up the bulk of FDA’s human drug spending under President Obama’s fiscal 2014 budget proposal, a trend fueled by new user fee programs and cuts to taxpayer funding.